Background: BRAF mutations, the most common genetic alteration associated with papillary
thyroid carcinoma (PTC), have never been associated with follicular thyroid carcinoma (FTC) …

Introduction Activating mutations of the BRAF oncogene are frequently detected in papillary
thyroid carcinoma (PTC) and have been associated with a worse prognosis. The amino acid …

BRAF mutations represent the most common genetic alteration in papillary thyroid
carcinoma (PTC). The p. V600E mutation is specific for the classic and tall-cell variants of …

BRAF gene mutations are identified in about 45% of papillary thyroid carcinomas (PTC) and
represent the most common genetic event in this tumor. Here, we report a case of PTC, solid …

BRAF gene mutations have been frequently detected in papillary thyroid carcinoma (PTC).
Moreover, there is a close association between the type of mutation and the PTC histotype …

Mutation of the BRAF gene is common in thyroid cancer. Follicular variant of papillary thyroid
carcinoma is a variant of papillary thyroid carcinoma that has created continuous diagnostic …

Objective The somatic point mutation in the BRAF gene, which results in a valine-to-
glutamate substitution at residue 600 (BRAFV600E), is an ideal hallmark of papillary thyroid …

Background: BRAF mutation is the most common genetic event in papillary thyroid
carcinoma (PTC); however, the prevalence and patterns of the mutation vary worldwide. We …

The BRAF p. V600E mutation represents the most specific marker for papillary thyroid
carcinoma and is potentially related to aggressive behavior and persistent disease. BRAF …

Activating mutations of BRAF have been identified in a variety of human cancers, most
notably melanomas and papillary thyroid carcinomas (PTCs). The aim of the present study …